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SUMMARY
Nigella sativa (N. sativa), commonly known as black seed, has been a well known herb since ancient times with
a wide range of healing properties. The aim of this study was to investigate anti-inflammatory activity of N. sativa seed
oil at three dosages on carrageenan-induced paw oedema, total white blood cell (TWBC) count and plasma protein in
rats. Acute inflammation was induced by subplantar injection of carrageenan (0.1 ml, 1 % w/v) into the rat hind paw.
500 mglkg, 1000 mg/kg and 1500 mg/kg of N. sativa oil were administrated orally. Paw oedema, total white blood cell
count and plasma protein were assessed. N. sativa seed oil exerted significant inhibition of paw oedema at the dosage
of 1500 mg/kg at second hour and plasma protein at a dosage of 1000 mg/kg at third hour (p< 0.05). No significant
inhibition ofTWBC count was exerted by N. sativa seed oil at third hour after treatment at dosages used in this study.
There was also dose-dependent correlation of N. sativa seed oil on inhibition of paw oedema. These results support the
traditional use of N. sativa seed oil for the treatment of inflammatory diseases.
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INTRODUCTION
Nigella sativa is an annual herbaceous plant that
belongs to the Ranunculaceae family. N. sativa,
commonly known as black cumin, love in the mist, fitch,
and fithches, is a beautiful Middle Eastern herb with many
medicinal uses. The seeds of this plant are called black
seeds or black cumin. It is a native plant that is widely
distributed in Egypt and other parts of the world (Jansen,
1981).
Mature seeds are usually consumed for edible and
medical purposes. It has been commonly used as a natural
food additive and as a prevention and cure for many
ailments in the Middle East and South East Asia for over
2000 years. InEgyptian folk medicine, the seeds are used
as carminatives, diuretics, and for delayed menses and
lactation, while their oil has protective action against
cough and asthma (Soliman, 1978).
The Prophet Muhammad (Peace Be Upon Him) said
in his divine wisdom about the black seeds, "Hold onto
the use of the black seed for it has a remedy for every
illness except death" (reference to the hadith - Sahih
Bukhari).
Black seed is a complex substance of more than 100
compounds, some of which have not been identified or
studied. The specific seed constituents that have been
identified and investigated include fixed oils, saponins,
volatile or essential oils, alkaloids and amino acids. It
also has traces of calcium, iron, sodium, potassium and
crude fiber. The fixed oils constitute 35% of the seed with
an unsaturated fatty acid constituent of73.5% of the fatty
acid composition in the seed oil (Atta, 2003). Amino acid
analysis of the seed's protein hydrolysate showed the
presence of 15 amino acids, including all nine essential
amino acids (AI-Gaby, 1998).
N. sativa has been reported to exhibit many
pharmacological effects including anticestode and
antinematode (Mahmoud et al., 2002), antifungal (Khan
et al., 2003), anti-inflammatory (AI-Ghamdi, 2001),
antihistamine activity (Chakravarty, 1993), antitumor
(Kumara and Huat, 2001), lactogogue (Agarwal et al.,
1979), antidiabetic (AI-Haderetal.,1993), antiulcerogenic
(Akhtar et al., 1996), diuretic (Zaoui et al., 2000) and
treatment of dyslipidemia and hyperglycaemia (Zaoui et
al.,2002).
The present study was therefore undertaken to
investigate further the anti-inflammatory effect of Nigella
sativa oil at different dosages on carrageenan-induced paw
oedema, total white blood cell count and plasma protein
in rats.
MATERIALS AND METHODS
Animals
Thirty female Spraque-Dawley rats, weighing 150-
250 g were used in this study. All animals were kept under
standard conditions. They were fed with standard pellets
and water ad libitum. Experiments were performed
between 08:00am. and 3:00pm.
Testmaterials
Baraka" 450 mg soft gelatin capsule produced by
Pharco Pharmaceutical, Alexandria, Egypt was used in
this study. Each capsule contains 0.45 ml of N. sativa L.
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seed oil (El-Baraka seed oil) which contains various
constituents including nigellone, fatty acids, glycosides,
phenolic components, carotene, minerals, phosphorus and
iron and some digestive enzymes.
Ketofen" 5 mg produced by Merial was used in this
study as a positive control drug. Each tablet contained
5 mg of ketoprofen.
Lambda-carrageenan" manufactured by Sigma-
Aldrich was used to induce acute inflammation of rat paw.
Experiment protocol
Animals were divided into five groups with six rats
in each group. The five-animal groups received 500,
1000, 1500 mg/kg of N. sativa oil, 1mg/kg of keto prof en
(positive control) and no treatment (negative control),
respectively. All treatments were administered orally.
A volume ofO.l ml of 1% sterile _-carrageenan was
injected into the subplantar of the right hind paw of the
rats, an hour after the drug treatment, while the
contralateral paw was injected with 0.1 ml of sterile
normal saline.
The paw volume was measured before carrageenan
injection and every hour subsequently for a period of 4
hours using water displacement technique (Al-Ghamdi,
2001). A line was marked around the hock joint of both
hind limbs before the experiment. The increase in paw
volume was measured by dipping the paw until the hock
joint in a calibrated syringe filled with water. The
displaced water volume was recorded at O.Olml accuracy.
Blood was collected via intracardiac puncture by
using a 26G needle with the animal under chloroform
anaesthesia. One ml of blood was withdrawn each time
and collected into EDTA tubes. Blood sampling was done
just before and 3 h after carrageenan injection. Blood
samples in the EDTA tubes were stored at 4°C and
analysed within 24 h of collection. The rats were
euthanised after the fourth hour when all necessary
.procedures had been performed.
Analytical procedures
Carrageenan-induced oedema was measured as
follows. The paw volume is the difference between right
and left paw volume. Paw oedema volume is the
difference of paw volume after and before treatment with
carrageenan. Percentage of inhibition was calculated using
the following formula:
Percentage of inhibition = 100(1- : =;)
where a is the mean paw volume of treated rats after
carrageenan injection
x is the mean paw volume of treated rats
before carrageenan injection
b is the mean paw volume of control rats after
carrageenan injection
y is the mean paw volume of control rats before
carrageenan injection
Total white blood cells were counted manually by
using a haemocytometer. Plasma was separated from
blood by using microhaematocrit centrifuge. Plasma
protein level was determined by using a refractometer.
Statistical analysis
Data were expressed as mean and standard error mean
(S.E.M.). Pearson correlation coefficient was used to
evaluate correlation between different dosages of N. sativa
oil on paw oedema. One-way-ANOVA test followed by
Dunnet multiple comparison tests were used to determine
significant differences between different treatment groups
for paw oedema. Significant differences between, before
and after treatment for total white blood cell count and
plasma protein were tested by paired r-test, P-values less "
than 0.05 (p< 0.05) were considered as indicative of
significance.
RESULTS
The subplantar injection in the right hind paw with
carrageenan induced a progressive oedema in the rats
without any treatment (negative control group). Animals
treated with Nigella sativa oil and ketoprofen showed
reduction in paw oedema compared with animals without
any treatment (Table 1). The anti-inflammatory effect of
N. sativa oil was dose-dependent and similar to that of
ketoprofen (Table 1). Animals treated with ketoprofen
showed significant inhibition of the paw oedema from 2
to 4 h after carrageenan injection (p< 0.05), compared to
animals without any treatment.
However, N. sativa oil only produced significant
inhibition (p < 0.05) at a higher dosage of 1500 mg/kg at
2 h with an inhibition effect ofS8.4%. Correlation between
the paw oedema volume and the corresponding N. sativa
dosage was found to be significant at first hour (r=
-0.470, p < 0.05), highly significant at second hour
(r = -0.S4S,P< 0.01) and significant at third hour (r=-
0.428, p < 0.05).
Total white blood cell (TWBC) count increased
significantly in negative control group (p < 0.05) as shown
in Table 2. Animals treated with ketoprofen at a dose rate
of 1mg/kg showed a significant reduction in TWBC count
three hours after treatment (p < 0.05). However, there
was no significant difference in TWBC counts in animals
treated with N. sativa 3 h after and before treatments.
The negative control group showed a significant
increase in the plasma protein 3 h after carrageenan
injection (p < 0.05). Positive control group and Nigella
sativa oil at a dose rate of 1000 mg/kg showed a significant
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Table 1: Effects of N.sativa oil (NSO) on carrageenan-induced paw oedema in rats
2 h" 4h
Paw oedema % Paw oedema % Paw oedema % Paw oedema %
volume (ml) Inhibition volume (ml) Inhibition volume (ml) Inhibition volume (ml) Inhibition
NSO 500 mg/kg 0.29±0.26 26.6 0.47 ± 0.18 32.8 0.59 ± 0.43 30.9 0.78 ± 0.28 17.1
NSO 1000mg/kg 0.10±0.05 41.6 0.29 ± 0.20 47.7 0.42 ± 0.09 38.0 0.63 ± 0.12 20.6
NSO 1500mg/kg 0.06±0.01 76.6 0.21 ± 0.05* 58.4 0.37 ± 0.10 48.4 0.63 ± 0.43 22.8
Ketoprofen 1mg/kg 0.18 ± 0.10 30.5 0.24 ± 0.08* 51.0 0.21 ± 0.09* 73.6 0.20 ±0.01* 76.0
(positive control)
No treatment 0.26±0.08 0.55 ± 0.25 0.71 ± 0.17 0.82 ± 0.27 -B
(Negative control)
Values represent the mean ± S.E.M. of 6 animals for each group.
• p < 0.05 compared with -ve control group
+ Correlation is significant at the 0.05 level.
++ Correlation is significant at the 0.01 level.
Treatment
Table 2: Effects of N. sativa oil (NSO) on total white blood cell count and plasma protein in rats
Plasma protein (gil)Total white blood cell count (x 109/1»
Oh 3h Oh 3h
NSO 500 mg/kg
NSO 1000mg/kg
NS01500 mg/kg
Ketoprofen 1mg/kg (positive control)
No treatment (negative control)
7.17 ± 2.16
7.5 ± 1.56
9.57 ± 3.56
9.59 ± 1.25
11.18 ± 4.28
10.28 ± 3.51
9.78 ± 3.34
10.78 ± 5.24
6.29 ± 1.59·
16.10 ± 5.94·
76.2 ± 3.4
75.7 ± 2.7
68.8 ± 6.8
12.8 ± 4.3
57.7 ± 4.7
78.3 ± 4.1
70.3 ± 3.7·
62.3 ± 5.4
65.8 ± 4.2·
62.0 ± 4.7·
• p < 0.05 compared with before treatment.
Values represent the mean ± S.E.M. of 6 animals for each group.
p < 0.05 reduction in the plasma protein. However, there
was no significant reduction of plasma protein after 3 h
of carrageenan injection following administration of the
Nigella sativa oil at dose rates of 500 mg/kg or 1500 mg!
kg. This could probably be due to the high standard error
mean (S.E.M.) in plasma protein values before and after
treatment. This was mainly contributed by data from two
animals which gave high level of plasma protein values
before and after treatment.
DISCUSSION
The results showed that N. sativa has anti-
inflammatory action comparable to that of 1 mg/kg of
ketoprofen. This study showed that animals treated with
1500 mg/kg of N. sativa oil exhibited significant inhibition
of paw oedema. Al-Ghamdi (2001) reported significant
inhibition at 500 mg/kg of N. sativa seeds crude
suspension. The variation of the result may be due to the
volume of carrageenan of the same concentration used in
both the studies. In the present study, 0.1 ml of
carrageenan was used and half ofthe volume was used to
induce acute inflammation in the latter study.
According to Di Rosa et al. (1971), histamine and
serotonin were mainly released during first 1.5 h after
carrageenan injection. Kinin was released from 1.5 to
2.5 h, followed by prostaglandins until 5 h after
carrageenan injection. From the results obtained in this
work, oral administration of 1500 mg/kg of N. sativa oil
produced significant inhibition of the release of kinin.
However, this study was unable to establish significant
inhibition of the release of histamine, serotonin and
prostaglandins in a model of acute inflammation.
Haq et al. (1995) in their study of the effect on human
lymphocytes by N. sativa indicated that N. sativa oil
activates T-Iymphocytes to secrete interleukin-3 (IL-3)
and interleukin-l ; (IL-l _). IL-3 is derived from activated
T cells: T-helper 1 and T-helper 2, eosinophils and mast
cells, while, IL-l_ is produced mainly by macrophages.
Both IL-3 and IL-l_ are important examples of
chemotactic agents that stimulate chemotaxis of
leucocytes (Macfarlane et al., 2000). Activation of T-
lymphocytes to secrete both IL-3 and IL-l _ by N. sativa
oil may contribute to the increase in total white blood
cell count shown in the present study.
Chakravarty (1993) reported that nigellone in
relatively low concentrations is very active in inhibiting
histamine release from rat peritoneal cells by different
secretagogues. The researcher suggested that N. sativa
directly inhibits mast cells through the protein kinase C.
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El-Dakhakhny et al. (2000) also reported a significant
decrease in gastric mucosal histamine in rats treated with
880 mglkg N. sativa oil daily for 2 weeks via oral route.
No significant inhibition of paw oedema one hour after
carrageenan injection suggested that N. sativa at dosages
used in this study have little ability to inhibit relatively
higher amounts of histamine released from connective
tissue mast cells.
There was no significant inhibition and correlation
of paw oedema between different dosages of N. sativa 4
h after carrageenan injection. This finding supports the
postulate suggested by AI- Ghamdi (2001) thatN. sativa
oil may not inhibit the synthesis of prostaglandins. N.
sativa did not exhibit antipyretic effects in that study, as
prostaglandins cause a rise in body temperature during
inflammation. Indeed, increased secretion of both IL-3
and IL- L are important in eliciting the pain of
inflammation and causing the release of prostaglandins
(Tizard,1996).
Inflammation stimulates the synthesis of certain
globulins (__t-globulins and _z-globulins) by hepatocytes
and perhaps immunoglobulins (lg) by B-Iymphocytes.
Several cytokines, especially interleukin-6 (lL-6), alter
protein synthesis in or protein release from hepatocytes
(Stockham and Scott, 2002). Inhibition of plasma protein
in this study suggests that there is inhibition of some
cytokines or protein from hepatocytes by N. sativa seed
oil in a model of acute inflammation.
N. sativa showed an anti-oxidant activity by
suppressing the chemiluminescence (Haq et al., 1995).
The authors also observed no significant difference in
killing rates, phagocytic rate and phagocytic activity of
polymorphonuclear cells (PMNs) without N. sativa or
with different concentrations of N. sativa, indicating that
N. sativa did not exert bactericidal activity. In line with
this, our study also found no significant effect of different
concentrations of N. sativa on total white blood cell
counts. The suppression of chemiluminescence but not
bactericidal activity would suggest that N. sativa inhibits
PMN myeloperoxidase activity.
No reduction in total white blood cell count in this
study indicated no inhibition in the migration of the
leucocytes to affected site at treatment dosages. This may
be attributed to no inhibition of some chemical mediators
that cause emigration of leucocytes (Tizard, 1996).
These results support the traditional use of N. sativa
seed oil for the treatment of inflammatory diseases. N.
sativa seed oil exerts its pharmacological activity on acute
inflammation induced by 0.1 ml of 1% carrageenan in rat
paw by causing a significant reduction in paw oedema
volume at a dose rate of 1500 mglkg at 2 h and the plasma
protein at dose rate of 1000 mglkg at 3 h. However, N.
sativa seed oil did not cause any reduction in total white
blood cell count at dosages used in this investigation.
REFERENCES
Agarwal, R., Kharya, M.D. and Shrivastava, R. (1979).
Antimicrobial and anthelmintic activities of the
essential oil of Nigella sativa Linn. Ind. J. Exp. Bioi.
17:1264-1265.
Akhtar, A.H., Ahmad, K.D., Gilani, S.N. and Nazir, A.
(1996). Antiulcer effects of aqueous of Nigella sativa
and Pongamia pinnata in rats. Fitoterapia 67: 195-
199.
Al-Gaby, A.M. (1998). Amino acid composition and
biological effects of supplementing broad bean and
com proteins with Nigella sativa (black cumin) cake
protein. Nahrung 42(5): 290-294.
Al-Ghamdi, M.S. (2001). The anti-inflammatory,
analgesic and antipyretic activity of Nigella sativa. J.
Ethnopharmacol. 76: 45-48.
AI-Hader, A., Aqel, M. and Hassan, Z. (1993).
Hypoglycaemic effects of the volatile oil of Nigella
sativa seeds. International Journal ofPharmacognosy
31: 96-100.
Atta, M.B. (2003). Some characteristics of Nigella
(Nigella sativa L.) seed cultivated in Egypt and its
lipid profile. Food Chemistry 83: 63-68.
Chakravarty, N. (1993). Inhibition of histamine release
from mast cells by nigellone. Ann. Allergy 70(3):237-
242.
DiRosa, M., Giround, J.P. and Willougbby, D.A. (1971).
Studies of the mediators of the acute inflammatory
response induced in rats in different sites by
carrageenan and turpentine. J. Pathol. 104:15-29
El-Dakhakhny, M., Barakat, M., Abd El-Halim and M.
Aly, S.M. (2000). Effect of Nigella sativa oil on gastric
secretion and ethanol induced ulcer in rats. J.
Ethnopharmacol. 72: 299-304.
Haq, A., Abdullatif, M., Lobo, P.I., Khabar, K.S., Sheth,
K.V. and Al-Sedairy, S.T. (1995),Nigellasativa: effect
on human lymphocytes and polymorphonuclear
leukocyte phagocytic activity. Immunopharmaco!ogy
30: 147-155.
Jansen, P.C.M. (1981). Spices, Condiments and Medicinal
Plants in Ethiopia, Their Taxonomy, and Agricultural
Significance. Center for Agricultural Publishing and
Documentation, Addis Ababa.
ANTI-INFLAMMATORY ACTMTY OF NIGELLA SATIVA OIL IN RATS
Khan, M.A., Ashfaq, M.K., Zuberi, H.S., Mahmood, M.S,
and Gilani, AH. (2003). The in vivo antifungal activity
of the aqueous extract from Nige/la sativa seeds.
Phytother. Res. 17(2): 183-186.
Kumara, S.S. and Huat, B.T. (2001). Extraction, isolation
and characterisation of antitumor principle, alpha-
hederin, from the seeds of Nige/la sativa. Planta. Med.
67(1): 29-32.
Macfarlane, P.S., Reid, R. and Callander, R. (2000).
Pathology Illustrated. Churchill Livingstone.
Mahmoud, M.R., EI-Abhar, H.S. and Saleh, S. (2002).
The effect of Nigella sativa oil against the liver damage
induced by Schistosoma mansoni infection in mice.
J. Ethnopharmacol. 79(1): 1-11.
Soliman, S.N. (1978). A pharmacognostical study of
certain Nigella species growing in Egypt, MSc. thesis,
Chairo Univ., Egypt.
19
Stockham, S.L. and Scott, M.A. (2002). Fundamental of
. Veterinary Clinical Pathology. Iowa State Press.
Tizard, I.R. (1996). Veterinary Immunology. An
Introduction. W.B. Saunders Co.
Zaoui, A., Cherrah, Y., Lacaille-Dubois, M.A, Settaf, A,
Amarouch, H. and Hassar, M. (2000). Diuretic and
hypotensive effects of Nigella sativa in the
spontaneously hypertensive rat. Therapie 55(3): 379-
382.
Zaoui, A., Cherrah, Y., Alaoui, K., Mahassine, N.,
Amarouch, H. and Hassar, M. (2002). Effect of
Nigella sativa fixed oil on blood homeostasis in rats.
J. Ethnopharmacol. 79: 23-26.
